Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124851402 | 12485140 | 2 | F | 20160609 | 20160711 | 20160621 | 20160720 | EXP | PH-NOVOPROD-496581 | NOVO NORDISK | 68.00 | YR | E | M | Y | 60.00000 | KG | 20160720 | CN | PH | PH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124851402 | 12485140 | 1 | PS | NOVOSEVEN RT | COAGULATION FACTOR VIIA RECOMBINANT HUMAN | 1 | Intravenous (not otherwise specified) | 5 MG, QD | FU60159 | 103665 | 5 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124851402 | 12485140 | 1 | Procedural haemorrhage |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124851402 | 12485140 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124851402 | 12485140 | Haemorrhage | |
| 124851402 | 12485140 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124851402 | 12485140 | 1 | 20160609 | 20160609 | 0 |